Elliott Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,500,338
| Closed | -$247M | – | 21 |
|
2025
Q1 | $247M | Hold |
3,500,338
| – | – | 1.63% | 6 |
|
2024
Q4 | $230M | Hold |
3,500,338
| – | – | 1.38% | 8 |
|
2024
Q3 | $246M | Hold |
3,500,338
| – | – | 1.27% | 8 |
|
2024
Q2 | $288M | Hold |
3,500,338
| – | – | 1.66% | 7 |
|
2024
Q1 | $306M | Buy |
3,500,338
+500,000
| +17% | +$43.7M | 1.9% | 6 |
|
2023
Q4 | $289M | Buy |
+3,000,338
| New | +$289M | 1.55% | 9 |
|